The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer.
 
Per Eystein Lonning
Stock and Other Ownership Interests - Cytovation Limited
Honoraria - Abbvie; AstraZeneca; Pierre Fabre; Roche
Consulting or Advisory Role - AstraZeneca; Laboratorios Farmaceuticos Rovi
Speakers' Bureau - Akademikonferens (Sweden); Aptitude Health
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - The company by which I am a shareholder (Cytovation) holds several patents. I have no patens apart from that.
Travel, Accommodations, Expenses - Pierre Fabre
 
Oleksii Nikolaienko
No Relationships to Disclose
 
Kathy Pan
No Relationships to Disclose
 
Allison W. Kurian
Research Funding - Myriad Genetics (Inst)
Other Relationship - Ambry Genetics; Color Genomics; GeneDx/BioReference; Genentech; InVitae
 
Hans Petter Petter Eikesdal
Honoraria - AstraZeneca; Bristol-Myers Squibb; Dagens Medisin; Daiichi Sankyo Europe GmbH; Gilead Sciences; HAI Interaktiv AS; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; MSD; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst)
Expert Testimony - Exact Sciences/Oecona; Pfizer; ProCure; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Dagens Medisin; Daiichi Sankyo Europe GmbH; Gilead Sciences; MSD; Novartis
 
Mary Pettinger
No Relationships to Disclose
 
Garnet L Anderson
Research Funding - Mars Symbioscience (Inst)
 
Ross L Prentice
No Relationships to Disclose
 
Rowan T. Chlebowski
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; genentech; Immunomedics; Novartis
Speakers' Bureau - AstraZeneca; novartis
 
Stian Knappskog
Honoraria - AstraZeneca/Merck; Pfizer; Pierre Fabre
Research Funding - AstraZeneca/Merck (Inst); Illumina (Inst); Pfizer (Inst)